Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | 2C14H24N6O4.2C2H3O2.Cu |
| Molecular Weight | 862.39 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cu++].CC([O-])=O.CC([O-])=O.NCCCC[C@H](NC(=O)[C@H](CC1=CNC=N1)NC(=O)CN)C(O)=O.NCCCC[C@H](NC(=O)[C@H](CC2=CNC=N2)NC(=O)CN)C(O)=O
InChI
InChIKey=LUNQZVCDZKODKF-PFVVTREHSA-L
InChI=1S/2C14H24N6O4.2C2H4O2.Cu/c2*15-4-2-1-3-10(14(23)24)20-13(22)11(19-12(21)6-16)5-9-7-17-8-18-9;2*1-2(3)4;/h2*7-8,10-11H,1-6,15-16H2,(H,17,18)(H,19,21)(H,20,22)(H,23,24);2*1H3,(H,3,4);/q;;;;+2/p-2/t2*10-,11-;;;/m00.../s1
| Molecular Formula | Cu |
| Molecular Weight | 63.546 |
| Charge | 2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C2H3O2 |
| Molecular Weight | 59.044 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C14H23N6O4 |
| Molecular Weight | 339.3702 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Prezatide is a tripeptide molecule consisiting of lysine, glycine and histidine, also known as GHK (glycyl-L-histidyl-L-lysine), that forms a complex with copper ions. Prezatide is used in cosmetic products (skin and hair) and is known help wound healing. Prezatide increases the synthesis and deposition of type I collagen and glycosaminoglycan. It is thought to play a role in the modulation of tissue remodeling by increases the expression of matrix metalloproteinase-2, as well as tissue inhibitor of matrix metalloproteinases-1 and -2. Prezatide has antioxidant activity due to its ability to supply copper for superoxide dismutase and anti-inflammatory ability due to the blockage the of iron (Fe2+) release during injury.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:11:49 GMT 2025
by
admin
on
Mon Mar 31 18:11:49 GMT 2025
|
| Record UNII |
A3LEI4P1NB
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000081611
Created by
admin on Mon Mar 31 18:11:49 GMT 2025 , Edited by admin on Mon Mar 31 18:11:49 GMT 2025
|
PRIMARY | |||
|
DBSALT002420
Created by
admin on Mon Mar 31 18:11:49 GMT 2025 , Edited by admin on Mon Mar 31 18:11:49 GMT 2025
|
PRIMARY | |||
|
CC-72
Created by
admin on Mon Mar 31 18:11:49 GMT 2025 , Edited by admin on Mon Mar 31 18:11:49 GMT 2025
|
PRIMARY | |||
|
m5722
Created by
admin on Mon Mar 31 18:11:49 GMT 2025 , Edited by admin on Mon Mar 31 18:11:49 GMT 2025
|
PRIMARY | Merck Index | ||
|
1314596
Created by
admin on Mon Mar 31 18:11:49 GMT 2025 , Edited by admin on Mon Mar 31 18:11:49 GMT 2025
|
PRIMARY | RxNorm | ||
|
A3LEI4P1NB
Created by
admin on Mon Mar 31 18:11:49 GMT 2025 , Edited by admin on Mon Mar 31 18:11:49 GMT 2025
|
PRIMARY | |||
|
130120-57-9
Created by
admin on Mon Mar 31 18:11:49 GMT 2025 , Edited by admin on Mon Mar 31 18:11:49 GMT 2025
|
PRIMARY | |||
|
6955
Created by
admin on Mon Mar 31 18:11:49 GMT 2025 , Edited by admin on Mon Mar 31 18:11:49 GMT 2025
|
PRIMARY | |||
|
SUB10033MIG
Created by
admin on Mon Mar 31 18:11:49 GMT 2025 , Edited by admin on Mon Mar 31 18:11:49 GMT 2025
|
PRIMARY | |||
|
A3LEI4P1NB
Created by
admin on Mon Mar 31 18:11:49 GMT 2025 , Edited by admin on Mon Mar 31 18:11:49 GMT 2025
|
PRIMARY | |||
|
DTXSID00156359
Created by
admin on Mon Mar 31 18:11:49 GMT 2025 , Edited by admin on Mon Mar 31 18:11:49 GMT 2025
|
PRIMARY | |||
|
C171726
Created by
admin on Mon Mar 31 18:11:49 GMT 2025 , Edited by admin on Mon Mar 31 18:11:49 GMT 2025
|
PRIMARY | |||
|
9876021
Created by
admin on Mon Mar 31 18:11:49 GMT 2025 , Edited by admin on Mon Mar 31 18:11:49 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |